期刊
STEM CELL REPORTS
卷 17, 期 7, 页码 1714-1729出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2022.05.018
关键词
-
资金
- Japan Agency for Medical Research and Development (AMED) [JP19bk0104080h, JP19bm0504005h]
- Osaka Eye Bank Research Grant 2020
This study investigated the impact of human leukocyte antigen (HLA) on corneal epithelial cell sheet (CEPS) transplantation. The results showed that there was no difference in immune response to CEPS between HLA-matched and -unmatched peripheral blood mononuclear cells. Additionally, programmed death ligand 1 was identified to have an immunosuppressive effect on CEPS under inflammatory conditions.
When corneal epithelial stem cells residing in the corneal limbus become dysfunctional, called a limbal stem cell deficiency (LSCD), corneal transparency is decreased, causing severe vision loss. Transplantation of corneal epithelial cell sheets (CEPS) derived from stem cells, including induced pluripotent stem cells, is a promising treatment for LSCD. However, the potential effect of human leukocyte antigen (HLA) concordance on CEPS transplantation has not been addressed. Here, we show that there is no difference in the immune response to CEPS between HLA-matched and -unmatched peripheral blood mononuclear cells in mixed lymphocyte reactions. CEPS transplantation in cynomolgus monkeys revealed that the immune response to major histocompatibility-unmatched CEPS was not strong and could be controlled by local steroid administration. Furthermore, programmed death ligand 1 was identified as an immunosuppressive molecule in CEPS under inflammatory conditions in vitro. Our results indicate that corneal epithelium has low immunogenicity and allogeneic CEPS transplantation requires mild immunosuppression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据